Management of Shirobhitapa w.s.r to Essential Hypertension - A Case Study
Abstract
Hypertension is called a silent killer because it rarely causes symptoms before it damages the heart, kidneys or brain. It is estimated that 600 million people are affected worldwide with hypertension. By the year 2025, approximately 1 in 3 adults aged over 20 years, totally 1.56 billion people worldwide, will have hypertension. Many works have been carried out on hypertension to evaluate the perfect diagnosis and mode of treatment on the basis of Ayurvedic principles, different nomenclatures also have been adopted by Ayurvedic scholars like Shonitamada, Raktagata Vyana Vayu, Shiragatavata, Rakta Chapa, Raktavrita Vata, Raktavriddhi, Raktavata etc.
Downloads
References
https://en.wikipedia.org/wiki/Essential_hypertension
https://pubmed.ncbi.nlm.nih.gov/14730320-trends-inhypertension-epidemiology-in-india/
WHO report of prevention and control for Cardio vascular diseases, 2001‑2002. Available from: http://www.sld.cu/./pdf/./international_cardiovascular _disease_statistics.page2. [Last cited on 2002 Aug 25].
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365:217‑23.)
Agnivesha, Charaka samhita, Dipika commentary of Chakrapanidatta, edited by Vaidya Jadavaji Trikamaji Acharya, 5th edition, Varanasi Chaukhamba publications, 2001, p 124)
Agnivesha, Charaka, Dridhabala, Charaka Samhita, Sutra Sthana, Trishothiya Adhyaya, 18/44, Vaidya Jadavji Trikamji Acharya, editor, 2nd ed.
Varanasi: Chaukhamba Sanskrit Sansthan; 2008. p. 108.)
Hemlata soni, kartar singh bansaliamj ayurvedic management of essential hypertention a case study issn: 2320 5091
Bhramanand Tripathi. Charaka Samhita. Sharirsthana (3/17), Chaukhambha Subharti Prakashan, Varanasi, reprint edition, 2009;p.872.
Anantram Sharma. Sushruta Samhita, Sharirsthana (4/36), Chaukhambha Surbharti Prakashan, reprint edition, 2004;p.57.
Anantram Sharma, Sushruta Samhita, Sutra Sthana (24/5), Chaukhambha Surabharti Prakashan,reprint edition, 2004;p.202.
Anantram Sharma. Sushruta Samhita, NidanaSthana (1/20), Chaukhambha Subharti Prakashan, reprint edition 2004;p.459.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444 798/
Bhramanand Tripathi. Charaka Samhita, Sutra Sthana (24/05), Chaukhambha Surabharti Prakashan, Varanasi, reprint edition,2009;p.429.
Bhramanand Tripathi. Charaka Samhita, Sutra Sthana (26/42), Chaukhambha Surabharti Prakashana, reprint edition, 2009;p.483.
Bhramanand Tripathi, Charaka Samhita, Vimana Sthana (1/15,18), Chaukhambha Surabharti Prakashan, Varanasi, reprint edition, 2009;p.660-661.
Anantram Sharma. Sushruta Samhita. ChikitsaSthana (24/30-31), Chaukhambha Surabharti Prakashan, reprint edition, 2004;p.581.
Anantram Sharma. Sushruta Samhita. Uttara Sthana (47/03). Chaukhambha Surabharti Prakashana, reprint edition, 2004;p.383.
Charaka Samhita of Agnivesha with Ayurvedadipika commentary of Chakrapani Dutta, Sutra Sthana 24/11-16, Edited by Vaidya Yadavji Trikamji Acharya, published by Chaukhambha publication, 2005.
Charaka Samhita of Agnivesha with Ayurveda dipika commentary of Chakrapani Dutta, Sutra Sthana 28/11- 13, Edited by Vaidya Yadavji Trikamji Acharya, published by Chaukhambha publication, 2005.
M. Menon, A. Shukla / Journal of Ayurveda and Integrative Medicine 9 (2018) 302e307
Daksha Kanaksinh Rathod, Jour. of Ayurveda & Holistic Medicine, Volume-V, Issue-V (Sept.- Oct. 2017), ISSN- 2321-1563.
Kuldeep et al.Int J Ayu Pharm Chem 2018 Vol. 8 Issue 3[e ISSN 2350-0204] 24. Shukla, et al.: Efficacy of Virechana and Basti Karma in essential hypertension, AYU | Jan-Mar 2013 | Vol 34 | Issue 1
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
